143 related articles for article (PubMed ID: 2990329)
1. Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
Zerial A; Werner GH; Phillpotts RJ; Willmann JS; Higgins PG; Tyrrell DA
Antimicrob Agents Chemother; 1985 May; 27(5):846-50. PubMed ID: 2990329
[TBL] [Abstract][Full Text] [Related]
2. Antirhinovirus compound 44,081 R.P. inhibits virus uncoating.
Alarcon B; Zerial A; Dupiol C; Carrasco L
Antimicrob Agents Chemother; 1986 Jul; 30(1):31-4. PubMed ID: 3019236
[TBL] [Abstract][Full Text] [Related]
3. [Chemoprophylaxis and chemotherapy of common colds caused by rhinoviruses: overview and outlook].
Werner GH
Bull Acad Natl Med; 1992 May; 176(5):669-81. PubMed ID: 1330221
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of R 61837, a new antirhinovirus compound.
Andries K; Dewindt B; De Brabander M; Stokbroekx R; Janssen PA
Arch Virol; 1988; 101(3-4):155-67. PubMed ID: 2845889
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
[TBL] [Abstract][Full Text] [Related]
6. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).
al-Nakib W; Higgins PG; Barrow GI; Tyrrell DA; Andries K; Vanden Bussche G; Taylor N; Janssen PA
Antimicrob Agents Chemother; 1989 Apr; 33(4):522-5. PubMed ID: 2543283
[TBL] [Abstract][Full Text] [Related]
7. RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compound.
Ash RJ; Parker RA; Hagan AC; Mayer GD
Antimicrob Agents Chemother; 1979 Sep; 16(3):301-5. PubMed ID: 228594
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers.
Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Lenox-Smith I
J Antimicrob Chemother; 1984 Oct; 14(4):403-9. PubMed ID: 6094423
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug.
DeLong DC; Reed SE
J Infect Dis; 1980 Jan; 141(1):87-91. PubMed ID: 6245149
[TBL] [Abstract][Full Text] [Related]
10. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides.
Ninomiya Y; Shimma N; Ishitsuka H
Antiviral Res; 1990 Feb; 13(2):61-74. PubMed ID: 2160796
[TBL] [Abstract][Full Text] [Related]
13. Controlled trial of enviroxime against natural rhinovirus infections in a community.
Miller FD; Monto AS; DeLong DC; Exelby A; Bryan ER; Srivastava S
Antimicrob Agents Chemother; 1985 Jan; 27(1):102-6. PubMed ID: 2984980
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection.
Hayden FG; Gwaltney JM
Antimicrob Agents Chemother; 1982 Jun; 21(6):892-7. PubMed ID: 6287928
[TBL] [Abstract][Full Text] [Related]
15. Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Choi HJ; Song JH; Lim CH; Baek SH; Kwon DH
J Med Food; 2010 Apr; 13(2):326-8. PubMed ID: 20412019
[TBL] [Abstract][Full Text] [Related]
16. Rhinovirus inactivation by nasal tissues treated with virucide.
Hayden GF; Gwaltney JM; Thacker DF; Hendley JO
Antiviral Res; 1985 Apr; 5(2):103-9. PubMed ID: 2990332
[TBL] [Abstract][Full Text] [Related]
17. Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
Ishitsuka H; Ninomiya YT; Ohsawa C; Fujiu M; Suhara Y
Antimicrob Agents Chemother; 1982 Oct; 22(4):617-21. PubMed ID: 6295261
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
19. Virucidal hand treatments for prevention of rhinovirus infection.
Turner RB; Hendley JO
J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
Décor A; Grand-Maître C; Hucke O; O'Meara J; Kuhn C; Constantineau-Forget L; Brochu C; Malenfant E; Bertrand-Laperle M; Bordeleau J; Ghiro E; Pesant M; Fazal G; Gorys V; Little M; Boucher C; Bordeleau S; Turcotte P; Guo T; Garneau M; Spickler C; Gauthier A
Bioorg Med Chem Lett; 2013 Jul; 23(13):3841-7. PubMed ID: 23726345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
